Related references
Note: Only part of the references are listed.PP261 Development Of A Mapping Algorithm To Predict SF-6D Values In People With Drug-Resistant Focal Onset Seizures
India Flint et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2021)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Gregory L. Krauss et al.
LANCET NEUROLOGY (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
Terence J. O'Brien et al.
EPILEPSIA (2020)
Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
Steve S. Chung et al.
NEUROLOGY (2020)
Cost-effectiveness of surgery for drug-resistant temporal lobe epilepsy in the US
Shehryar R. Sheikh et al.
NEUROLOGY (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multi-centre, double-blind, randomised, placebo-controlled, dose-response trial (vol 19, pg 38, 2020)
G. L. Krauss et al.
LANCET NEUROLOGY (2020)
Burden in caregivers of adults with epilepsy in Asian families
Siew-Tim Lai et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
High risk of anxiety and depression in caregivers of adult patients with epilepsy and its negative impact on patients' quality of life
Xue-Rui Zhu et al.
EPILEPSY & BEHAVIOR (2019)
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Gregory L. Krauss et al.
EPILEPSIA (2018)
EQ-5D-based utilities and healthcare utilization in Thai adults with chronic epilepsy
Panumart Phumart et al.
EPILEPSY & BEHAVIOR (2018)
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
Zhibin Chen et al.
JAMA NEUROLOGY (2018)
A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy
Ben F. M. Wijnen et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
Retention of perampanel in adults with pharmacoresistant epilepsy at a single tertiary care center
Tim Wehner et al.
EPILEPSY & BEHAVIOR (2017)
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials
Victor Biton et al.
EPILEPSY & BEHAVIOR (2017)
Long-term adjunctive lacosamide treatment in patients with partial-onset seizures
F. Rosenow et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
A systematic review of neuropsychiatric comorbidities in patients with both epilepsy and intellectual disability
Jans S. van Ool et al.
EPILEPSY & BEHAVIOR (2016)
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
Elinor Ben-Menachem et al.
NEUROLOGY (2016)
Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial
J. A. French et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Caring for a family member with intellectual disability and epilepsy: Practical, social and emotional perspectives
Rose Thompson et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2014)
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305
Jacqueline A. French et al.
EPILEPSIA (2013)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
Quality of life in adult patients with epilepsy and their family members
Romy Mahrer-Imhof et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304
Jacqueline A. French et al.
NEUROLOGY (2012)
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta-analysis
Joao Costa et al.
EPILEPSIA (2011)
Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
Peter Halasz et al.
EPILEPSIA (2010)
Add-on treatment with pregabalin for partial seizures with or without generalisation: Pooled data analysis of four randomised placebo-controlled trials
Antonio Gil-Nagel et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2009)
Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs
CE Selai et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
A pooled analysis of adjunctive topiramate in refractory partial epilepsy
K Peeters et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Share Paper
